Product & regulatory approvals

Gates that opened: regulatory and product approvals — drug approvals, licences, clearances — disclosed to the exchanges inside the window. The approval filing is linked on every row.

CompanyWhy it’s here — the filingReaction 1d / 1w / 1mPriceMcapP/EROCERev YoY
Raghav Productivity Enh LElectrodes & RefractoriesPatent granted for ramming mass production process21 Aug 2026Regulatory Product Approval×3pending₹1,6957,782 Cr135.8vs 49.127.4%+11.0%
Titagarh Rail SystemsRailway WagonsVendor approval for 3-Phase Locomotive Traction Motor from Indian Railways19 Aug 2026Regulatory Product Approval+1.8% ₹84511,378 Cr56.07.4%+9.6%
Strides Pharma SciPharmaceuticalsStrides gets USFDA clearance for Bengaluru plant19 Aug 2026Regulatory Product Approval+3.0% ₹9849,070 Cr13.8vs 28.516.6%+8.4%
PCBL ChemicalCarbon BlackPCBL gets ECMS approval for Acetylene Black Project worth Rs 329 cr18 Aug 2026Regulatory Product Approval+2.9% ₹31812,503 Cr148.53.4%-4.5%
Man Industries (I)Iron & Steel ProductsMan Industries wins PML approval from QatarEnergy for LSAW pipes14 Aug 2026Regulatory Product Approval+8.0% ₹7185,384 Cr24.5vs 16.99.8%+38.8%
FDCPharmaceuticalsFDC subsidiary gets UK MHRA approval for Atropine eye drops13 Aug 2026Regulatory Product Approval+0.3% ₹3485,667 Cr21.5vs 28.514.7%+23.6%
Apollo Micro SystemsAerospace & DefenseMD letter covers Premier Explosives acquisition and new defence wins8 Aug 2026Regulatory Product Approval-3.5% -4.4% ₹38213,645 Cr107.3vs 60.310.4%+30.2%
Astrazeneca Pharma Ind LTPharmaceuticalsAstraZeneca India gets CDSCO nod for Enhertu additional indication8 Aug 2026Regulatory Product Approval×2-3.2% -8.5% ₹7,40018,500 Cr119.4vs 28.525.0%+3.5%
Guj Nar Val Fer & Chem LCommodity ChemicalsGNFC Gets Positive Rs 61 Crore Impact from Revised Urea Energy Norms1 Aug 2026Regulatory Product Approval+1.8% +7.8% ₹5848,589 Cr7.9vs 17.510.3%+12.2%
Mas Financial ServNon Banking Financial Company (NBFC)MAS Financial gets UIDAI approval for Aadhaar authentication services31 Jul 2026Regulatory Product Approval-2.6% -4.5% ₹3015,467 Cr14.0vs 17.5+13.0%
Alembic PharmaPharmaceuticalsAlembic Pharma gets USFDA nod for Prucalopride Tablets 1mg and 2mg28 Jul 2026Regulatory Product Approval-0.7% +2.4% ₹81916,093 Cr24.0vs 28.511.2%-3.3%
How this list is built

A company appears when an NSE/BSE filing inside the last 30 days carries one of these classifier signals (minimum importance: Medium): Regulatory Product Approval. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.

MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.